{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:57:00Z","timestamp":1790211420082,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,20]]},"DOI":"10.7759\/cureus.79379","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T20:17:47Z","timestamp":1740082667000},"source":"Crossref","is-referenced-by-count":1,"title":["Adopting a Collaborative Strategy to Address the Complexities of Implanting a Subcutaneous Implantable Cardiac Defibrillator for Secondary Prevention in a Patient With Fabry Disease and Motor Neuron Disease"],"prefix":"10.7759","author":[{"given":"Sumantra Kumar","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elton","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmanabhan","family":"Shakkottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjith","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Fabry Disease","author":"Bokhari SRA","year":"2025","unstructured":"Bokhari SRA, Zulfiqar H, Hariz A. Fabry Disease. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2022.07.010","article-title":"An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease","volume":"137","author":"Germain DP","year":"2022","unstructured":"Germain DP, Altarescu G, Barriales-Villa R, et al.. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease. Mol Genet Metab. 2022, 137:49-61. 10.1016\/j.ymgme.2022.07.010","journal-title":"Mol Genet Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094434","article-title":"Fabry disease and the heart: a comprehensive review","volume":"22","author":"Azevedo O","year":"2021","unstructured":"Azevedo O, Cordeiro F, Gago MF, Miltenberger-Miltenyi G, Ferreira C, Sousa N, Cunha D. Fabry disease and the heart: a comprehensive review. Int J Mol Sci. 2021, 22:4434. 10.3390\/ijms22094434","journal-title":"Int J Mol Sci"},{"key":"ref4","unstructured":"An introduction to motor neurone disease (MND). (2023). https.\/\/www.mndassociation.org\/media\/141."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.078600","article-title":"Cardiomyopathy in motor neuron diseases","volume":"77","author":"Gdynia HJ","year":"2006","unstructured":"Gdynia HJ, Kurt A, Endruhn S, Ludolph AC, Sperfeld AD. Cardiomyopathy in motor neuron diseases. J Neurol Neurosurg Psychiatry. 2006, 77:671-3. 10.1136\/jnnp.2005.078600","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2016.1170150","article-title":"Case report of concurrent Fabry disease and amyotrophic lateral sclerosis supports a common pathway of pathogenesis","volume":"17","author":"Beer AM","year":"2016","unstructured":"Beer AM, Cooper-Knock J, Fletcher S, Brown-Wright SH, Nandakumar TP, Shaw PJ. Case report of concurrent Fabry disease and amyotrophic lateral sclerosis supports a common pathway of pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener. 2016, 17:614-6. 10.3109\/21678421.2016.1170150","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref7","unstructured":"The Eyegaze Edge\u00ae. (2024). Accessed. 22 February, 2024: https:\/\/eyegaze.com\/."},{"key":"ref8","article-title":"Motor Neuron Disease","author":"Arora RD","year":"2025","unstructured":"Arora RD, Khan YS. Motor Neuron Disease. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jen132","article-title":"Fabry's disease presenting as ventricular tachycardia and left ventricular 'hypertrophy'","volume":"9","author":"Joshi SB","year":"2008","unstructured":"Joshi SB, Ahmar W, Lee G, Aggarwal A. Fabry's disease presenting as ventricular tachycardia and left ventricular 'hypertrophy'. Eur J Echocardiogr. 2008, 9:697-9. 10.1093\/ejechocard\/jen132","journal-title":"Eur J Echocardiogr"},{"key":"ref10","unstructured":"Diagnosis and management of cardiac manifestations in Anderson Fabry disease and glycogen storage diseases. (2024). Accessed. 22 February, 2024: https:\/\/www.escardio.org\/static-file\/Escardio\/Subspecialty\/Working%20Groups\/Myocardial%20and%20Pericardial%20Diseases...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux261","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"Baig S","year":"2018","unstructured":"Baig S, Edward NC, Kotecha D, et al.. Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice. Europace. 2018, 20:f153-61. 10.1093\/europace\/eux261","journal-title":"Europace"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02053-2","article-title":"Arrhythmogenesis in Fabry Disease","volume":"26","author":"Roy A","year":"2024","unstructured":"Roy A, Cumberland MJ, O'Shea C, et al.. Arrhythmogenesis in Fabry Disease. Curr Cardiol Rep. 2024, 26:545-60. 10.1007\/s11886-024-02053-2","journal-title":"Curr Cardiol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14113","article-title":"Time to rechallenge primary prevention ICD guidelines","volume":"9","author":"Wong B","year":"2022","unstructured":"Wong B, McDonald K, Keane D. Time to rechallenge primary prevention ICD guidelines. ESC Heart Fail. 2022, 9:3694-7. 10.1002\/ehf2.14113","journal-title":"ESC Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/321017-adopting-a-collaborative-strategy-to-address-the-complexities-of-implanting-a-subcutaneous-implantable-cardiac-defibrillator-for-secondary-prevention-in-a-patient-with-fabry-disease-and-motor-neuron-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T20:17:49Z","timestamp":1740082669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/321017-adopting-a-collaborative-strategy-to-address-the-complexities-of-implanting-a-subcutaneous-implantable-cardiac-defibrillator-for-secondary-prevention-in-a-patient-with-fabry-disease-and-motor-neuron-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.79379","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}